Sign in

Michael Fischbach

@mfgrp.bsky.social
1.2K followers 27 following 55 posts

Liu (Liao) Family Professor of Bioengineering, ChEM-H @Stanford.

PostsRepliesMedia
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Major distinguishing feature: it is *pre-emptive*. The host reaches outside, grabs bacteria (or bacterial fragments), brings them inside, & develops an immune response against them. In a very real sense, the host is *vaccinating itself* against the colonist. 41/55
2254
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
OK, so what did we learn? Let's start w/ the initial question: What does the immune system intend to do when it sees a colonist? Don't want to over-generalize, but at least for S. epi, the immune response is much more pathogen-like that we had realized. 40/55
161
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Aap-sc-TTFC & the conventional vaccine both elicit a potent response in the bloodstream. However, when we looked in the pulmonary & nasal mucosa, we found that Aap-sc-TTFC had elicited a strong IgA response; the conventional nanoparticle vaccine had not. 39/55
140
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
To our surprise, Aap-sc-TTFC elicited a massive response - even stronger than the original genetically encoded (Aap-TTFC) strain, and almost as potent as the hottest conventional vaccine we could find. Titers from engineered S. epi are stronger than a typical mRNA vaccine. 36/55
1130
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Djenet engineered S. epi to express a variant of Aap that displays SpyCatcher. When she incubated these cells with recombinant GFP-SpyTag, not only were the cells labeled but the copy number was very high (we estimate ~40,000-50,000/cell). 32/55
160
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Christopher had a clever idea. He had been making nanoparticle vaccines in which the particle bears a SpyCatcher domain, the immunogen is SpyTagged, and the two 'click' together spontaneously. Why not express SpyCatcher on the surface of S. epi? 31/55
151
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Djenet (wisely) ignored my advice and decided to do it anyway. Having received no help from me, she did what everyone in my lab does when they run into trouble: walked downstairs to consult @cobarnes27.bsky.social. 30/55
1100
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
She proposed an alternative: make the immunogen in mammalian cells and then attach it (after the fact) to S. epi. I dismissed the idea, arguing that the bacterial cells would divide, the immunogen would dilute, and the antibody response would be weak. Seemed inelegant. 29/55
150
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
...which were (more than) sufficient to protect against a lethal challenge by tetanus toxin. 26/55
171
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
When she colonized mice with an engineered strain of S. epi displaying TTFC within Aap, the mice developed very high titers of antibody against TTFC... 25/55
141
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
She tried a few different strategies. The one that worked best was to replace the parallel beta-helix domain with our model antigen, a C-terminal fragment from tetanus toxin (TTFC) that is non-toxic but can elicit immunity against tetanus. 24/55
141
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Having seen that the antibody response targets a giant cell surface protein, Djenet wondered: what if we express a non-native immunogen on the cell surface? Will the mice develop immunity against the new antigen? 23/55
172
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
It consists entirely of repeat sequences. The B domain (& blue N-terminal domain) are direct amino acid repeats, while the beta-solenoid is a structural repeat. All of these presumably fold cooperatively after snaking through the secretion pore. 21/55
191
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Aap is a giant (140 kDa) tree-like protein whose rigid 'trunk' (the B domain) sticks straight up through the peptidoglycan meshwork, displaying a parallel beta-helix domain that extends above the arbor on the bacterial surface. 20/55
161
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
There are only 9 predicted sortase substrates in the two S. epi isolates we used. Djenet narrowed it down to one that is the predominant (though not exclusive) target of the antibody response: a truly bizarre protein named Aap. 19/55
161
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Indeed there was: a mutant missing the gene that encodes sortase, the enzyme responsible for attaching proteins to the cell wall of Gram-positive bacteria. This made things easy - sortase substrates can be ID'd computationally by their C-terminal LPXTG tag. 18/55
163
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
She took a series of S. epi mutants, each one missing a conserved structure on the cell surface. By incubating them with serum from a mouse colonized with the wild-type strain, she asked: is there a mutant to which the antibodies no longer bind? 17/55
132
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Next, Djenet wanted to figure out: what molecule on the bacterial cell surface is the target of the antibody response? 16/55
121
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Our paper went in a different direction. First, Djenet asked whether the antibody response to S. epi is conserved in humans. She found that serum samples from healthy adults harbor very high levels of IgG against common strains of S. epi. More on this below. 15/55
141
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
They report that S. epi induces a tertiary lymphoid structure near the site of colonization; antibodies are made in this structure and in conventional germinal centers in the draining lymph node. Langerhans cells are required for all of this to happen... 13/55
153
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Shortly thereafter, we learned that Inta Gribonika in the Belkaid lab had made a similar observation (neither of us realized we were both working on it!). Yasmine is one of my dearest collaborators; we coordinated our efforts from that point forward. 12/55
160
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Unlike a normal antibody response following vaccination - which rises after the prime, falls back down, and rises again after the boost - the antibody response to S. epi keeps rising and rising until ~6 weeks... and then stays there indefinitely. 11/55
1111
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
The experiment was very simple. We didn't prep the mice in any way; Djenet dipped a Q-tip in a bacterial culture and gently swabbed the head of the mouse. The result was striking: not only is there a systemic antibody response, but it is extremely potent. 10/55
192
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
So she decided to test whether, in addition to T cells, there was a B cell response as well. 9/55
180
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Djenet grew suspicious that the immune response against this (generally harmless) commensal might be more aggressive than we had realized. When the adaptive immune system means business, both arms are typically engaged. 8/55
190
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
...and it is pre-emptive: it occurs in the absence of infection or inflammation, across an intact barrier. Given that microbial residents of the gut, skin, and nasal cavity are thought to be generally mutualistic, what is the purpose of this response? 5/55
1110
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
By comparison, the immune response to microbial colonists is puzzling. Three of its features are notable: its tone is determined by the microbial elicitor; it is antigen-specific, just like an anti-pathogen response... 4/55
1130
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
The overarching question here: What does the immune system intend to do when it sees a colonist? To frame this, let's posit that the immune response to a pathogen has a clear goal: limiting replication and dissemination to prevent the host from dying. 3/55
1130
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @djenetbousbaine.bsky.social led the charge... @natureportfolio.bsky.social 1/55
23693294